Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study

Inflammatory Bowel Diseases(2024)10.1093/ibd/izae203Source: DataRank Database

Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study is a research paper published in Inflammatory Bowel Diseases (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: bronzeTopics (19)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Pankhuri Jha ORCID,Jaime A. Pérez ORCID,Elleson Harper,Preetika Sinh ORCID,Gregory Cooper ORCID

Live enrichment

PubMed:39259586 OpenAlex:https://openalex.org/W4402433607

Clinical and Translational Science Collaborative of Northern Ohio

Grant: UM1TR004528

FWCI

0.00

Citation Percentile

0.1%

bronzeLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

journalhttps://academic.oup.com/ibdjournal/article-pdf/31/4/1168/59087555/izae203.pdf

publisherhttps://academic.oup.com/ibdjournal/article-pdf/31/4/1168/59087555/izae203.pdf

publisherhttps://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izae203/59087555/izae203.pdf

journalhttps://doi.org/10.1093/ibd/izae203

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39259586

Fields of Study

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesImmunodeficiency and Autoimmune Disorders

Keywords

MedicineRheumatoid arthritisInflammatory bowel diseaseTumor necrosis factor alphaInternal medicineInfliximabGastroenterologyDiseaseAntirheumatic AgentsArthritisRisk factorImmunologyInflammatory arthritisNecrosisTumor necrosis factor αTumor Necrosis Factor Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being